Arash Naeim1, Arti Hurria, Barbara Leake, Rose C Maly. 1. Division of Hematology-Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1687, USA. anaeim@mednet.ucla.edu
Abstract
PURPOSE: To evaluate the treatment patterns of women aged 55 years or older with newly diagnosed breast cancer and to examine the association between age and ethnicity/race on treatment selection. METHODS: A cross-sectional survey between January 1 and June 30, 2001 of 401 women was performed of Hispanic, black and non-Hispanic white women in Los Angeles County, aged 55 years or older with newly diagnosed breast cancer. Regression analysis examined the association between: (a) age and treatment selection and (b) ethnicity/race and treatment selection, adjusting for the effect of possible confounders. RESULTS: In this study of urban breast cancer patients (64.1% response rate), blacks were less likely to receive hormone (OR=0.36) or chemotherapy therapy (OR=0.50) while older patients were less likely to receive lymph node dissection after lumpectomy (OR=0.48) and chemotherapy (OR=0.22). CONCLUSION: Although there are racial and age disparities in breast cancer treatment, other factors such as education, income status, insurance plan, functional status, and comorbidity also play an important role.
PURPOSE: To evaluate the treatment patterns of women aged 55 years or older with newly diagnosed breast cancer and to examine the association between age and ethnicity/race on treatment selection. METHODS: A cross-sectional survey between January 1 and June 30, 2001 of 401 women was performed of Hispanic, black and non-Hispanic white women in Los Angeles County, aged 55 years or older with newly diagnosed breast cancer. Regression analysis examined the association between: (a) age and treatment selection and (b) ethnicity/race and treatment selection, adjusting for the effect of possible confounders. RESULTS: In this study of urban breast cancerpatients (64.1% response rate), blacks were less likely to receive hormone (OR=0.36) or chemotherapy therapy (OR=0.50) while older patients were less likely to receive lymph node dissection after lumpectomy (OR=0.48) and chemotherapy (OR=0.22). CONCLUSION: Although there are racial and age disparities in breast cancer treatment, other factors such as education, income status, insurance plan, functional status, and comorbidity also play an important role.
Authors: Jennifer L Malin; Allison L Diamant; Barbara Leake; Yihang Liu; Amardeep Thind; Katherine L Kahn; Eric C Schneider; Arnold M Epstein; Rose C Maly Journal: J Clin Oncol Date: 2010-06-07 Impact factor: 44.544
Authors: Marie Crandall; Douglas Sharp; Karen Brasel; Mercedes Carnethon; Adil Haider; Thomas Esposito Journal: Surgery Date: 2011-10 Impact factor: 3.982
Authors: A M Brewster; C Etzel; R Zhou; Y Wong; S Edge; D W Blayney; J Wilson; C Hudis; R Ottesen; M E Hughes; J C Weeks; R L Theriault Journal: Breast Cancer Res Treat Date: 2011-08-02 Impact factor: 4.872
Authors: Jennifer J Griggs; Sarah T Hawley; John J Graff; Ann S Hamilton; Reshma Jagsi; Nancy K Janz; Mahasin S Mujahid; Christopher R Friese; Barbara Salem; Paul H Abrahamse; Steven J Katz Journal: J Clin Oncol Date: 2012-08-06 Impact factor: 44.544